These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23973519)

  • 1. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia.
    Şekerci ÇA; Işbilen B; Işman F; Akbal C; Şimşek F; Tarcan T
    J Urol; 2014 Jan; 191(1):199-205. PubMed ID: 23973519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity due to myelodysplasia.
    Top T; Sekerci CA; Isbilen-Basok B; Tanidir Y; Tinay I; Isman FK; Akbal C; Simsek F; Tarcan T
    Neurourol Urodyn; 2017 Sep; 36(7):1896-1902. PubMed ID: 28090659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary TIMP-2 and MMP-2 are significantly associated with poor bladder compliance in adult patients with spina bifida.
    Peyronnet B; Richard C; Bendavid C; Naudet F; Hascoet J; Brochard C; Senal N; Jezequel M; Alimi Q; Khene ZE; Corlu A; Clément B; Siproudhis L; Bouguen G; Kerdraon J; Manunta A; Gamé X
    Neurourol Urodyn; 2019 Nov; 38(8):2151-2158. PubMed ID: 31486131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographic measurement of bladder wall thickness as a risk factor for upper urinary tract deterioration in children with myelodysplasia.
    Tanaka H; Matsuda M; Moriya K; Mitsui T; Kitta T; Nonomura K
    J Urol; 2008 Jul; 180(1):312-6; discussion 316. PubMed ID: 18499168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of 99mtechnetium dimercapto-succinic acid renal scan in children with spina bifida during long-term followup.
    Shiroyanagi Y; Suzuki M; Matsuno D; Yamazaki Y
    J Urol; 2009 May; 181(5):2262-6; discussion 2266. PubMed ID: 19296988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment.
    Clayton DB
    J Urol; 2014 Jan; 191(1):205. PubMed ID: 24121036
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia.
    Sekerci CA; Tanidir Y; Toprak T; Basok BI; Isman F; Simsek F; Akbal C; Tarcan T
    J Urol; 2019 Jan; 201(1):174-180. PubMed ID: 30577408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary continence outcome after augmentation ileocystoplasty as a single surgical procedure in patients with myelodysplasia.
    Medel R; Ruarte AC; Herrera M; Castera R; Podesta ML
    J Urol; 2002 Oct; 168(4 Pt 2):1849-52. PubMed ID: 12352374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk determination for upper urinary tract damage in children with neuropathic bladder.
    Ekberlİ G; Taner S
    J Paediatr Child Health; 2023 Jul; 59(7):863-870. PubMed ID: 36999336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele.
    Korzeniecka-Kozerska A; Porowski T; Michaluk-Skutnik J; Wasilewska A; Płoński G
    Scand J Urol; 2013 Oct; 47(5):411-7. PubMed ID: 23301927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of upper tract damage in pediatric neurogenic bladder.
    Prakash R; Puri A; Anand R; Jain AK; Lal B; Garg V
    J Pediatr Urol; 2017 Oct; 13(5):503.e1-503.e7. PubMed ID: 28385450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?
    Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M
    J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for renal scarring in children and adolescents with lower urinary tract dysfunction.
    Leonardo CR; Filgueiras MF; Vasconcelos MM; Vasconcelos R; Marino VP; Pires C; Pereira AC; Reis F; Oliveira EA; Lima EM
    Pediatr Nephrol; 2007 Nov; 22(11):1891-6. PubMed ID: 17874252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of 86 patients with myelodysplasia and neurogenic bladder who underwent sigmoidocolocystoplasty and were followed more than 10 years.
    Hayashi Y; Yamataka A; Kaneyama K; Kato Y; Lane GJ; Miyano T
    J Urol; 2006 Oct; 176(4 Pt 2):1806-9. PubMed ID: 16945655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic and imaging findings in infants with myelomeningocele may predict need for future augmentation cystoplasty.
    Corona LE; Lee T; Marchetti K; S Streur C; Ivancic V; Kraft KH; Bloom DA; Wan J; Park JM
    J Pediatr Urol; 2019 Dec; 15(6):644.e1-644.e5. PubMed ID: 31653462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is 40 cm H
    Tarcan T; Sekerci CA; Akbal C; Tinay I; Tanidir Y; Sahan A; Sahin B; Top T; Simsek F
    Neurourol Urodyn; 2017 Mar; 36(3):759-763. PubMed ID: 27080436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does surgical release of secondary spinal cord tethering improve the prognosis of neurogenic bladder in children with myelomeningocele?
    Tarcan T; Onol FF; Ilker Y; Simsek F; Ozek M
    J Urol; 2006 Oct; 176(4 Pt 1):1601-6; discussion 1606. PubMed ID: 16952698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streamlining risk stratification in infants and young children with spinal dysraphism: Vesicoureteral reflux and/or bladder trabeculations outperforms other urodynamic findings for predicting adverse outcomes.
    Timberlake MD; Jacobs MA; Kern AJ; Adams R; Walker C; Schlomer BJ
    J Pediatr Urol; 2018 Aug; 14(4):319.e1-319.e7. PubMed ID: 30253979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for febrile urinary tract infection in children with myelodysplasia treated by clean intermittent catheterization.
    Seki N; Masuda K; Kinukawa N; Senoh K; Naito S
    Int J Urol; 2004 Nov; 11(11):973-7. PubMed ID: 15509200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.